Attendees didnt miss the opportunity to forge crucial collaborations and be part of the solution defining the future of GLP-1 treatments
Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, making it distinct from licensed agents such as semaglutide and tirzepatide
This highlights another significant barrier, the necessity of ongoing, long-term therapy to preserve weight management
Endothelial and granulosa cells exposed to oxidative or perfusion stress activate NF-B and stabilize HIF-1, respectively, programs that drive inflammatory and survival gene expression (e.g., IL-6, VEGF, glycolytic reprogramming) and that have been associated with impaired follicular function in ovarian pathology [58, 59]
PMC 8716657
As a result, researchers have begun exploring whether GLP-1 therapies may help reduce systemic inflammation